Genetic Code Expansion for Site-Specific Labeling of Antibodies with Radioisotopes.

Autor: Koehler C; VERAXA Biotech GmbH, Carl-Friedrich Gauß-Ring 5, 69124 Heidelberg, Germany.; Structural and Computational Biology Unit, European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany., Sauter PF; VERAXA Biotech GmbH, Carl-Friedrich Gauß-Ring 5, 69124 Heidelberg, Germany.; Structural and Computational Biology Unit, European Molecular Biology Laboratory, Meyerhofstrasse 1, 69117 Heidelberg, Germany., Klasen B; Department of Chemistry, TRIGA site, Johannes Gutenberg University, Fritz-Strassmann-Weg 2, 55128 Mainz, Germany., Waldmann C; Department of Nuclear Medicine, University Medical Center, Johannes Gutenberg University Langenbeckstraße 1, 55131 Mainz, Germany., Pektor S; Department of Nuclear Medicine, University Medical Center, Johannes Gutenberg University Langenbeckstraße 1, 55131 Mainz, Germany., Bausbacher N; Department of Nuclear Medicine, University Medical Center, Johannes Gutenberg University Langenbeckstraße 1, 55131 Mainz, Germany., Lemke EA; BIOCENTER, Johannes Gutenberg University, Hanns-Dieter-Hüsch-Weg 17, 55128 Mainz, Germany.; IMB Institute of Molecular Biology, gGmbH, Ackermannweg 4, 55128 Mainz, Germany., Miederer M; Department of Nuclear Medicine, University Medical Center, Johannes Gutenberg University Langenbeckstraße 1, 55131 Mainz, Germany.

Publikováno v: ACS chemical biology [ACS Chem Biol] 2023 Mar 17; Vol. 18 (3), pp. 443-448. Date of Electronic Publication: 2023 Mar 08.

Characterization of activation induced [18]F-FDG uptake in Dendritic Cells.

Autor: Pektor S; Department of Nuclear Medicine, University Medical Center Mainz, Germany., Lawaczeck L; Department of Nuclear Medicine, University Medical Center Mainz, Germany., Tenzer S; Institute for Immunology, University Medical Center Mainz, Germany., Bausbacher N; Department of Nuclear Medicine, University Medical Center Mainz, Germany., Hoffmann MA; Department of Nuclear Medicine, University Medical Center Mainz, Germany.; Federal Ministry of Defense, Department of Occupational Health & Safety, Bonn, Germany., Schreckenberger M; Department of Nuclear Medicine, University Medical Center Mainz, Germany., Miederer M; Department of Nuclear Medicine, University Medical Center Mainz, Germany.

Publikováno v: Nuklearmedizin. Nuclear medicine [Nuklearmedizin] 2021 Apr; Vol. 60 (2), pp. 90-98. Date of Electronic Publication: 2020 Dec 16.

Iodine-124 PET quantification of organ-specific delivery and expression of NIS-encoding RNA.

Autor: Miederer M; Department of Nuclear Medicine, University Medical Center of Johannes Gutenberg University, Mainz, Germany., Pektor S; Department of Nuclear Medicine, University Medical Center of Johannes Gutenberg University, Mainz, Germany., Miederer I; Department of Nuclear Medicine, University Medical Center of Johannes Gutenberg University, Mainz, Germany., Bausbacher N; Department of Nuclear Medicine, University Medical Center of Johannes Gutenberg University, Mainz, Germany., Keil IS; TRON - Translational Oncology at the University Medical Center, Johannes Gutenberg University Mainz gGmbH, Mainz, Germany., Hefesha H; Biopharmaceutical New Technologies (BioNTech) SE, Mainz, Germany., Haas H; Biopharmaceutical New Technologies (BioNTech) SE, Mainz, Germany., Sahin U; TRON - Translational Oncology at the University Medical Center, Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.; Biopharmaceutical New Technologies (BioNTech) SE, Mainz, Germany., Diken M; TRON - Translational Oncology at the University Medical Center, Johannes Gutenberg University Mainz gGmbH, Mainz, Germany. mustafa.diken@tron-mainz.de.; Biopharmaceutical New Technologies (BioNTech) SE, Mainz, Germany. mustafa.diken@tron-mainz.de.

Publikováno v: EJNMMI research [EJNMMI Res] 2021 Feb 10; Vol. 11 (1), pp. 14. Date of Electronic Publication: 2021 Feb 10.

PSA and PSA Kinetics Thresholds for the Presence of ⁶⁸ Ga-PSMA-11 PET/CT-Detectable Lesions in Patients With Biochemical Recurrent Prostate Cancer.

Autor: Hoffmann MA; Department of Occupational Health & Safety, Federal Ministry of Defense, 53123 Bonn, Germany.; Clinic of Nuclear Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany., Buchholz HG; Clinic of Nuclear Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany., Wieler HJ; Clinic of Nuclear Medicine, Bundeswehr Central Hospital, 56072 Koblenz, Germany., Miederer M; Clinic of Nuclear Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany., Rosar F; Clinic of Nuclear Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany.; Department of Nuclear Medicine, Saarland University Medical Center, 66421 Homburg, Germany., Fischer N; Department of Urology, Helios Kliniken Krefeld, 47805 Krefeld, Germany., Müller-Hübenthal J; Practice of Radiology and Nuclear Medicine, Praxis im KölnTriangle, 50679 Köln, Germany., Trampert L; Clinic of Nuclear Medicine, Klinikum Mutterhaus der Borromäerinnen, 54290 Trier, Germany., Pektor S; Clinic of Nuclear Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany., Schreckenberger M; Clinic of Nuclear Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany.

Publikováno v: Cancers [Cancers (Basel)] 2020 Feb 08; Vol. 12 (2). Date of Electronic Publication: 2020 Feb 08.

Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy.

Autor: Renner K; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany; Regensburg Center for Interventional Immunology, Regensburg, Germany. Electronic address: kathrin.renner-sattler@ukr.de., Bruss C; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Schnell A; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Koehl G; Department of Surgery, University Hospital Regensburg, Regensburg, Germany., Becker HM; Division of General Zoology, University of Kaiserslautern, Kaiserslautern, Germany., Fante M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Menevse AN; Regensburg Center for Interventional Immunology, Regensburg, Germany., Kauer N; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Blazquez R; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Hacker L; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Decking SM; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Bohn T; Institute for Immunology, University Medical Center Johannes Gutenberg University (UMC) Mainz, Mainz, Germany., Faerber S; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Evert K; Institute of Pathology, University of Regensburg, Regensburg, Germany., Aigle L; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Amslinger S; Institute of Organic Chemistry, University of Regensburg, Regensburg, Germany., Landa M; Institute of Organic Chemistry, University of Regensburg, Regensburg, Germany., Krijgsman O; Department Medical Oncology and Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Rozeman EA; Department Medical Oncology and Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Brummer C; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Siska PJ; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Singer K; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Pektor S; Department of Nuclear Medicine, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany., Miederer M; Department of Nuclear Medicine, University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany., Peter K; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Gottfried E; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Herr W; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Marchiq I; Institute of Research on Cancer and Aging (IRCAN), CNRS-INSERM-UNS UMR 7284, Nice, France., Pouyssegur J; Institute of Research on Cancer and Aging (IRCAN), CNRS-INSERM-UNS UMR 7284, Nice, France; Department of Medical Biology, Scientific Centre of Monaco (CSM), Monaco., Roush WR; Department of Chemistry, The Scripps Research Institute, Scripps-Florida, Jupiter, FL, USA., Ong S; NanoString Technologies, Seattle, WA, USA., Warren S; NanoString Technologies, Seattle, WA, USA., Pukrop T; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Beckhove P; Regensburg Center for Interventional Immunology, Regensburg, Germany., Lang SA; Department of General and Visceral Surgery, Medical Center, Faculty of Medicine University of Freiburg, Freiburg, Germany., Bopp T; Institute for Immunology, University Medical Center Johannes Gutenberg University (UMC) Mainz, Mainz, Germany; Research Center for Immunotherapy (FZI), UMC Mainz, Mainz, Germany; University Cancer Center Mainz, UMC Mainz, Mainz, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany., Blank CU; Department Medical Oncology and Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Cleveland JL; Department of Tumor Biology, Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Oefner PJ; Institute of Functional Genomics, University of Regensburg, Regensburg, Germany., Dettmer K; Institute of Functional Genomics, University of Regensburg, Regensburg, Germany., Selby M; Bristol-Myers Squibb, Redwood City, CA, USA., Kreutz M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany; Regensburg Center for Interventional Immunology, Regensburg, Germany.

Publikováno v: Cell reports [Cell Rep] 2019 Oct 01; Vol. 29 (1), pp. 135-150.e9.